Compare CAVA Group Inc (CAVA) vs Moderna, Inc. (MRNA) Price & Performance

CAVA Group IncTrade

Moderna, Inc.Trade

Price performance (Past 24H)

Key statistics

CAVA Group Inc vs Moderna, Inc. — how do they compare? CAVA Group Inc trades at $66.9 (market cap $7.17B), while Moderna, Inc. trades at $60.83 (market cap $23.88B). The key difference: Moderna, Inc. is far larger — about 3.3× CAVA Group Inc's market cap, and Moderna, Inc. is trading nearer its 52-week high, CAVA Group Inc nearer its low. Which is the better fit depends on your goals.

	CAVA	MRNA
Market Cap	$7.17B	$23.88B
Sector	Consumer Cyclical	Health
52-Week High	$97.39	$81.80
52-Week Low	$43.59	$22.36
Enterprise Value	$7.32B	$20.03B

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

CAVA Group Inc

CAVA trades at $62.42, up 0.31% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong revenue growth to $1.18B in 2025 and has beaten earnings estimates in two of the last three quarters. Recent news highlights anticipation for the Q2 2026 earnings report, with analysts citing strong traffic and expansion as positive catalysts.

Wall Street maintains a bullish outlook with a consensus price target of $91.00, though high valuation multiples and recent net cash outflows pose risks. The stock's investment case hinges on continued execution of its growth strategy amid competitive industry pressures.

Moderna, Inc.

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CAVA

CAVA Group set to report Q2 earnings with strong growth expected on Aug 11, 2026.Tony Dante · 19 hours agoBullish View details →

MRNA

New report analyzes 1,350+ precision medicine deals from 2019-2026, revealing market trends and deal structures.Researchandmarkets.Com · 4 days agoNeutral Global influenza vaccine market to grow to $13.32B by 2030, driven by aging population and vaccine innovationsResearchandmarkets.Com · 4 days agoNeutral View details →

About CAVA Group Inc

CAVA is a Mediterranean fast-casual restaurant brand in the US. It offers customizable bowls, salads, and pitas featuring healthy ingredients, while also selling its signature dips and dressings in grocery stores.

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.